Affordable Access

deepdyve-link
Publisher Website

Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.

Authors
  • Lee, Jiyeon1
  • Lim, Eunjin
  • Kim, Yumi
  • Li, Endan
  • Park, Seungjoon
  • 1 Department of Pharmacology, Biomedical Science Institute and Medical Science and Engineering Research Center for Bioreaction to Reactive Oxygen Species, School of Medicine, Kyung Hee University, Seoul 130-071, Republic of Korea. , (North Korea)
Type
Published Article
Journal
Journal of Endocrinology
Publisher
Bioscientifica
Publication Date
Jun 01, 2010
Volume
205
Issue
3
Pages
263–270
Identifiers
DOI: 10.1677/JOE-10-0040
PMID: 20351014
Source
Medline
License
Unknown

Abstract

Ghrelin is an endogenous ligand for GH secretagogue receptor type 1a (GHSR1a), and is produced and released mainly from the stomach. It has been recently demonstrated that ghrelin can function as a neuroprotective factor by inhibiting apoptotic pathways. Kainic acid (KA), an excitatory amino acid l-glutamate analog, causes neuronal death in the hippocampus; previous studies suggest that activated microglia and astrocytes actively participate in the pathogenesis of KA-induced hippocampal neurodegeneration. However, it is unclear whether ghrelin has neuroprotective effect in KA-induced hippocampal neurodegeneration. I.p. injection of KA produced typical neuronal cell death in the CA1 and CA3 pyramidal layers of the hippocampus, and the systemic administration of ghrelin significantly attenuated KA-induced neuronal cell death in these regions through the activation of GHSR1a. Ghrelin prevents KA-induced activation of microglia and astrocytes, and the expression of proinflammatory mediators tumor necrosis factor alpha, interleukin-1beta, and cyclooxygenase-2. The inhibitory effect of ghrelin on the activation of microglia and astrocytes appears to be associated with the inhibition of matrix metalloproteinase-3 expression in damaged hippocampal neurons. Our data suggest that ghrelin has a therapeutic potential for suppressing KA-induced pathogenesis in the brain.

Report this publication

Statistics

Seen <100 times